As noted previously, trial analysis is "ongoing" thus not completed. Also, compassionate use is/has been handled differently than the trial. More information sure seems to be pending, both from ongoing trial analysis as well as CU analysis. What that information will indicate seems to be the question currently at hand. I noted "inclusion" stated in regards to submission for getting Brilacidn into "government trials" (suggesting it isn't in some specific government trials at this moment) and "continuation" stated also suggesting some work somewhere has been ongoing. Who is involved and how relevant would that "continuing" work be and how persuasive would that continuing work be (in combination with ongoing trial and CU analysis) in getting Brilacidin into the "government trials"?